Mutations in the obese (ob) 
glucose injection significantly increased ob mRNA. For up to 30 min after glucose injection, ob mRNA in lean mice significantly correlated with plasma glucose, but not with plasma insulin. In a separate study with only lean mice, ob mRNA was inhibited >90% by fasting, and elevated -2-fold 30 min after i.p. injection of either glucose or insulin. These results suggest that in lean animals glucose and insulin enhance ob gene expression. In contrast to our results in lean mice, in obese animals ob mRNA is elevated and relatively insensitive to nutritional state, possibly due to chronic exposure to elevated plasma insulin and/or glucose.
Obesity is a major disorder associated with excessive mortality (1) . However, mechanisms leading to different forms of obesity are not well understood. Mutations in the obese (ob) gene result in obesity and hyperinsulinemia (2) . Parabiosis studies have suggested that the ob gene codes for a satiety factor (3) . The ob gene, recently isolated by positional cloning, codes for a product produced in and secreted by adipose tissue (4) . Injection of the ob gene product leptin reduced food intake, body weight, plasma glucose, and plasma insulin (5) (6) (7) . In a recent report, Maffei et al. (8) stated that "identification of the molecules that regulate expression of the ob gene in adipocytes ... will greatly enhance our understanding of the physiological mechanisms that regulate body weight". On the basis of the above observations, we hypothesized that glucose and/or insulin would stimulate expression of the ob gene. Studies demonstrating that leptin injections reduce body weight in obese mice (5) (6) (7) have suggested that some forms of obesity, like the ob/ob mouse, may be due to insufficient leptin production, and thus, like other hormone-deficient states, may be treatable by replacement therapy. On the other hand, if obesity is generally characterized by overexpression of the ob gene, as in db/db mice (8) , insensitivity to leptin, rather than
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. insufficient leptin production, may be a more common impairment, and efficacy of leptin may be limited. The yellow allele (AY) of the agouti gene is, like mutant alleles of the ob gene, associated with obesity, hyperinsulinemia, and hyperphagia (9) . The agouti gene has also been characterized, and its product appears to inhibit the action of melanocytestimulating hormone on its receptor (10) . We Fig. 1 A and B) , was persistently elevated in mice on a high-calorie diet for 14 weeks, compared to ob mRNA from mice on a normal diet (P < 0.05, two-way ANOVA, Fig. 1 C and D). The obesity-related elevation of ob mRNA was significant compared with lean animals, whether mice were fasted for 48 hr or fasted for 7 hr and injected with glucose (Tukey-Kramer; Fig. 1 C and D) . In lean mice ob mRNA was significantly elevated in 7-hr fasted, glucose-injected mice, compared to mice fasted for 48 hr (P < 0.05, Tukey-Kramer), but this effect of acute nutritional status was not significant in obese mice. Body weight and insulin were also significantly elevated in mice with diet-induced obesity (P < 0.05, ANOVA followed by Tukey-Kramer test, Fig. 1 C and D) . When lean and obese mice were analyzed together, analysis by linear regression indicated that ob mRNA correlated significantly with body weight (r = 0.79, P < 0.05), and insulin (r = 0.54, P < 0.05), but the correlation between ob mRNA and glucose did not achieve statistical significance (r = 0.4, P = 0.08).
The ob mRNA was also significantly elevated in genetically obese yellow mice, compared to ob mRNA from lean wild-type C57BL/6J mice (P < 0.05, two-way ANOVA, followed by Tukey-Kramer; Fig. 2 ). Furthermore, ob mRNA was significantly induced within 30 min after glucose injection in lean mice (P < 0.05, Tukey-Kramer; Fig. 2 ), but not in obese mice (P > 0.05, Tukey-Kramer; Fig. 2 ). Body weight and plasma insulin were significantly increased in obese mice (P < 0.05, ANOVA). Plasma glucose was significantly influenced by glucose injection (P < 0.05, two-way ANOVA), but not genotype (P > 0.05). Pooling across all groups, analysis by linear regression demonstrated that ob mRNA correlated significantly with body weight (r = 0.71, P < 0.05) and insulin (r = 0.45, P < 0.05). Within wild-type (lean) mice, ob mRNA was highly and significantly correlated with glucose (r = 0.81, P < 0.05; Fig. 3 ), but not body weight or insulin. Within genetically obese mice, ob mRNA did not correlate with glucose, body weight, or insulin (P > 0.05). These statistical relationships suggest that the differences in ob mRNA between lean mice and obese mice are more strongly related to group differences in body weight and insulin than to acute differences in plasma glucose. However, the individual differences in ob gene expression among lean mice (due to acute effects of glucose injection) may be related more to acute differences in plasma glucose than to acute differences in plasma insulin.
Furthermore, genetically obese mice appear to be relatively insensitive to these acute effects of glucose. Controlling for effects of the injection procedure, mice were sacrificed 30 minutes after an i.p. injection of saline, glucose, or insulin, after a 7-hr fast, or 30 min after an i.p. injection of saline after a 72-hr fast. In normal lean mice, ob mRNA was significantly influenced by these acute nutritional manipulations (P < 0.05, ANOVA). The ob mRNA in mice fasted for 7 hr was -10-fold higher than ob mRNA in mice fasted for 72 hr (P < 0.05, ANOVA followed by Tukey-Kramer test; Fig. 4) . Furthermore, in mice fasted for 7 hr, i.p. injection of either glucose or insulin resulted in -2-fold increase in ob mRNA 30 min after injection (P < 0.05, Tukey-Kramer, Fig. 4 ).
DISCUSSION
The product of the obese gene, leptin, is hypothesized to constitute a satiety factor, because absence of a functional obese gene in ob/ob mice leads to hyperphagia and obesity (2) , and injection of leptin reduces feeding and body weight in ob/ob mice (5-7). It was of particular interest that at the highest doses of leptin, mice with diet-induced obesity also lost weight (7). These results raised the possibility that, regardless of etiology, obesity might entail impaired production of leptin and might be reversible by injection of leptin. However, in the present study, we report that both diet-induced obesity and obesity due to the yellow agouti mutation were associated with dramatically elevated levels of ob mRNA. Because the expression of ob mRNA was normalized per mg of total RNA, the actual amount of total (presumably secreted) ob (8, 13) , obesity may be generally associated with elevated expression of the obese gene.
Elevated expression of the leptin gene in association with many forms of obesity suggests that obesity may generally be characterized by a relative insensitivity to leptin, rather than insufficient leptin production. Consistent with this hypothesis, 5-fold to 10-fold greater doses of leptin were required to produce an equivalent weight loss in mice with diet-induced obesity, compared to ob/ob mice (7). Thus, simply consuming a high-fat, high-carbohydrate diet appears to be associated with a remarkable loss of leptin sensitivity. Similarly, leptin insensitivity appears to be one of the effects of the yellow agouti mutation, whose obesity appears to be due to ectopic expression of an antagonist to melanocyte-stimulating hormone (10), the relationship of which to leptin action, if any, remains undefined. The general association of obesity with insensitivity to leptin may therefore limit the clinical efficacy of leptin in the treatment of human obesity.
The hypothesis that leptin constitutes a physiological satiety factor suggests that leptin might be induced by nutritional factors that produce satiety. The One of the earliest detectable differences between ob/ob mice (which lack functional ob gene product) and wild-type controls (which produce the ob gene product) is an elevation of plasma insulin in ob/ob mice before the development of obesity. Fourteen days after birth, plasma insulin is elevated in ob/ob mice, compared to wild-type controls (16) , whereas at this age neither food intake nor body weight differs between ob/ob and wild-type mice (17) . Such results suggest that an early effect of leptin is to inhibit insulin secretion, independent of its effects on feeding. The present studies suggest that integrated or chronic insulin levels are positively correlated with ob mRNA and that insulin injection can stimulate ob mRNA. Thus the elevation of ob mRNA in both acquired and genetic obesity (refs. 8, 13 , present studies) is plausibly related to the hyperinsulinemia that is associated with obesity. Therefore we hypothesize that insulin and leptin constitute a negative feedback loop, in which insulin (with glucose) stimulates leptin, and leptin inhibits insulin secretion, at least partly independent of its effects on feeding. The hypothesis that "ob mRNA was increased [in ob/ob mice] as part of a possible feedback loop" (4) could thus be explained as a failure in ob/ob mice to inhibit insulin secretion, in the absence of ob gene product. Conversely, the anti-obesity effect of the wild-type obese gene allele could be understood as being mediated, at least in part, by its effects in inhibiting insulin secretion. Further studies will be needed to address whether leptin acts at the pancreas to inhibit insulin secretion and whether blocking hyperinsulinemia in obesity will prevent the elevation of ob mRNA associated with obesity.
